It is well known that CF patients have higher oxidative stress in the lungs than healthy subjects due to increased ROS production, which is simultaneous with a deficit of antioxidant molecules, and these abnormalities, which are partly associated with GSH deficiency due to low CFTR activity, play a fundamental role in the progression of chronic lung damage [34]. The gene discussed is CFTR; the disease is cystic fibrosis.